Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer

Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer

Toll-like receptors (TLRs) belong to a germline-encoded protein family. These are pattern recognition receptors. They sense pathogen-associated molecular patterns (PAMPs). When this occurs, activation of the NF-ĸB pathway follows. This triggers the innate immune response of the host. The consequent...

Full description

Bibliographic Details
Main Authors:	Yingxiang Yang, Chengyue Jin, Anthony Yeo, Bo Jin
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2024/1111551

Similar Items

Of Flies and Men—The Discovery of TLRs
by: Hauke Johannes Weiss, et al.
Published: (2022-10-01)

The role of toll-like receptors (TLRs) in pan-cancer
by: Runzhi Huang, et al.
Published: (2022-12-01)

Activation of TLRs Triggers GLP-1 Secretion in Mice
by: Lorène J. Lebrun, et al.
Published: (2023-03-01)

TLRs direct haematopoietic precursor fate
by: Downes, J, et al.
Published: (2007)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01)

Multiple TLRs elicit alternative NLRP3 inflammasome activation in primary human monocytes independent of RIPK1 kinase activity
by: Sarah Unterberger, et al.
Published: (2023-10-01)

The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
by: Arturo Orlacchio, et al.
Published: (2021-11-01)

B cell TLRs and the antibody response to virus particles
by: DeFranco, A, et al.
Published: (2011)

Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
by: Gabriella M. Mazzotta, et al.
Published: (2023-04-01)

RNF115 Inhibits the Post‐ER Trafficking of TLRs and TLRs‐Mediated Immune Responses by Catalyzing K11‐Linked Ubiquitination of RAB1A and RAB13
by: Zhi‐Dong Zhang, et al.
Published: (2022-05-01)

Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
by: Xing Huang, et al.
Published: (2022-07-01)

TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
by: F. Linzee Mabrey, et al.
Published: (2021-10-01)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
by: Zhi-Mei Liu, et al.
Published: (2022-09-01)

Healthcare workers: occupational carcinogenic factors and cancer risk
by: L. G. Solenova, et al.
Published: (2018-11-01)

Oxidative Stress in the Carcinogenicity of Chemical Carcinogens
by: Hideki Wanibuchi, et al.
Published: (2013-10-01)

Environmental Carcinogens and Cancer Risk
by: Nicole M. Gatto
Published: (2021-02-01)

BIOCHEMICAL EFFECTS OF TLRs, CXCL12, AND NECROSOME ACTIVATION ON PRO-B LYMPHOCYTE APOPTOSIS IN THE PRESENCE OF FIBROBLASTS
by: Carmen (Amititeloaie) Gentimir, et al.
Published: (2022-08-01)

Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
by: Théo Ebermeyer, et al.
Published: (2021-07-01)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

Oncolytic Viruses for Multiple Myeloma Therapy
by: Christine M. Calton, et al.
Published: (2018-06-01)

Monitoring Therapeutic Side Effects (carcinogenic and non-carcinogenic) with Linked Cancer Registry Data in Australia
by: David Roder, et al.
Published: (2021-12-01)

Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases
by: Katarzyna Wicherska-Pawłowska, et al.
Published: (2021-12-01)

Chemical carcinogens: implications for cancer treatment
by: Shaofeng Liu, et al.
Published: (2023-10-01)

Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis
by: Kathryn Hally, et al.
Published: (2020-08-01)

TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
by: Stefania Mantovani, et al.
Published: (2023-04-01)

TLRs Gene Polymorphisms Associated with Pneumonia before and during COVID-19 Pandemic
by: Svetlana Salamaikina, et al.
Published: (2022-12-01)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
by: Georgia Stewart, et al.
Published: (2021-11-01)

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
by: Ahmet Hazini, et al.
Published: (2021-09-01)

Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity
by: Shihab Kochumon, et al.
Published: (2022-12-01)

Environmental Carcinogens
by: Perpustakaan UGM, i-lib
Published: (1992)

Chemical carcinogens /
by: Searle, Charles E.
Published: (1984)

Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01)

Oncolytic Adenovirus in Cancer Immunotherapy
by: Malin Peter, et al.
Published: (2020-11-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
by: Ralf Kircheis, et al.
Published: (2023-04-01)

Profiling of bovine toll like receptors (TLRs) in foot and mouth disease vaccinated cattle
by: RAJEEV RANJAN, et al.
Published: (2016-04-01)

Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy
by: Chao Fang, et al.
Published: (2023-01-01)

Effects of Salmonella Enteritidis infection on TLRs gene expression and microbial diversity in cecum of laying hens
by: Xintong Jiang, et al.
Published: (2023-06-01)

Effects of dietary supplementation of different herbs on relative expression of Toll-like Receptors (TLRs) in poultry
by: JYOTSANA, et al.
Published: (2023-05-01)

Relevance of Carcinogen-Induced Preclinical Cancer Models
by: Raj N. Sewduth, et al.
Published: (2024-01-01)